Diametric Capital, LP Burning Rock Biotech LTD Transaction History

Diametric Capital, LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$0.91 - $2.29 $13,165 - $33,131	-14,468 Reduced 34.21%	27,829 $26,000
Q2 2023 Aug 11, 2023	SELL	$2.15 - $3.16 $32,791 - $48,196	-15,252 Reduced 26.5%	42,297 $90,000
Q1 2023 May 11, 2023	SELL	$2.16 - $3.47 $74,854 - $120,252	-34,655 Reduced 37.59%	57,549 $161,000
Q4 2022 Mar 29, 2023	SELL	$1.73 - $2.95 $393,668 - $671,284	-227,554 Reduced 71.16%	92,204 $207,000
Q3 2022 Nov 14, 2022	BUY	$2.39 - $3.96 $501,307 - $830,617	209,752 Added 190.67%	319,758 $764,000
Q2 2022 Aug 15, 2022	BUY	$1.75 - $10.44 $192,510 - $1.15 Million	110,006 New	110,006 $320,000

21.2K

Ticker BNR
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 105,188,000
Market Cap $721M
Description
Burning Rock Biotech Limited primarily develops and provides cancer therapy selection tests in the People's Republic of China. It operates in three segments: Central Laboratory Business, In-Hospital Business, and Pharma Research and Development Services. The company primarily offers next-generation sequencing-based cancer therapy selection and p...

Get notified when there are updates to the investment portfolio of Diametric Capital, LP, based on Form 13F filings with the SEC.

Stay updated on Diametric Capital, LP with notifications on news.